| | | Page | | |||
| | | | 1 | | | |
| | | | 6 | | | |
| | | | 6 | | | |
| | | | 6 | | | |
| | | | 6 | | | |
| | | | 10 | | | |
| | | | 11 | | | |
| | | | 11 | | | |
| | | | 12 | | | |
| | | | 12 | | | |
| | | | 13 | | | |
| | | | 13 | | | |
| | | | 14 | | | |
| | | | 14 | | | |
| | | | 14 | | | |
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | 24 | | | |
| | | | | | ||
| | | | ||||
| |
| | | Page | | |||
| | | | 28 | | | |
| | | | 29 | | | |
| | | | 30 | | | |
| | | | 31 | | | |
| | | | 31 | | | |
| | | | 32 | | | |
| | | | 32 | | | |
| | | | 38 | | | |
| | | | 41 | | | |
| | | | 43 | | | |
| | | | 44 | | | |
| | | | 44 | | | |
| | | | 44 | | | |
| | | | 44 | | | |
| | | | 44 | | | |
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | | ||
| | | | | |
Name | | | Age | | | Principal Occupation and Business Experience | |
Jack C. Bendheim | | | | | Mr. Bendheim is Chairman of our Board of Directors and serves as our President and Chief Executive Officer. Mr. Bendheim has served as our President since 1988 and he was also appointed Chief Executive Officer in March 2014. He has been a director since 1984. Mr. Bendheim also serves as a member of the Compensation Committee. Mr. Bendheim joined us in 1969 and served as Chief Executive Officer from 1998 to 2002, as Chief Operating Officer from 1988 to 1998, as Executive Vice President and Treasurer from 1983 to 1988 and as Vice President and Treasurer from |
1975 to 1983. Until 2017, Mr. Bendheim also served on the Board of Directors of Empire Resources, Inc. Mr. Bendheim is also a past Chairman of the Animal Health Institute, an industry organization advocating for animal health issues, including efficient and effective FDA, USDA and EPA regulatory and approval processes. Mr. Bendheim, together with certain other family members, is a manager of BFI Co., LLC (“BFI”), an investment vehicle of the Bendheim family, with respect to the economic rights pertaining to shares of our stock owned by BFI. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI. Mr. Bendheim is the father of Daniel M. Bendheim and Jonathan Bendheim. Mr. Bendheim is qualified to serve on our Board of Directors due to his many years of experience in the animal health industry and with our Company in particular and his control over a majority of the voting rights in our common stock. | |
Name | | | Age | | | Principal Occupation and Business Experience | |
E. Thomas Corcoran | | | | | Mr. Corcoran has been a director since May 2008. Mr. Corcoran also serves as Chairman of the Audit Committee. Mr. Corcoran joined Fort Dodge Animal Health, a division of Wyeth, Inc., as its President in 1985. Wyeth was a research-based corporation with businesses focused on human health and animal health. Mr. Corcoran served on the Management, the Operations, the Legal, and the Human Resources and Benefits committees of Wyeth until his retirement in March 2008. From 2010 until 2016, Mr. Corcoran was a director of Putney, Inc., a pet pharmaceutical company. Mr. Corcoran also served as the Chairman of the Animal Health Institute, an industry organization advocating for animal health issues, including efficient and effective FDA, USDA and EPA regulatory and approval processes. Mr. Corcoran serves on the Board of Trustees of the University of South Alabama. Mr. Corcoran is a recipient of the Animal Pharm Lifetime Achievement Award, the Banfield Industry Leadership Award, the Lifetime Achievement Award from the American Veterinary Distributors Association and the Industry Leadership Award from the Kansas City Animal Health Corridor. Mr. Corcoran is a recipient of the Distinguished Alumni Award from the University of South Alabama. Mr. Corcoran is qualified to serve on our Board of Directors due to his extensive experience and executive leadership in the animal health industry. | | |
Dr. George Gunn | | | | | Dr. Gunn has been a director since May 2015. Dr. Gunn also serves as a member of the Compensation Committee. Dr. Gunn is the Chief Executive Officer and a director of Stonehaven Consulting AG, which provides business strategy consulting in the life sciences industry. After joining Novartis AG in 2003, Dr. Gunn served as the head of Novartis’s Animal Health business unit from 2004 until 2015, when the business was sold. Dr. Gunn served on Novartis’s Executive Committee from 2008 to 2015. In addition to these roles, Dr. Gunn served in various positions at Novartis including head of Animal Health, North America from 2003 to 2004, division head, Novartis Consumer Health from 2008 to 2011, and head of Corporate Social Responsibility from 2011 to 2014. Before his time at Novartis, Dr. Gunn was global head of Animal Health at Pharmacia Corporation from 2000 to 2003 and served in various leadership roles in animal health, over-the-counter medicines, human pharmaceuticals and nutraceuticals at Johnson & Johnson from 1985 to 2000. Prior to this, Dr. Gunn worked in a technical advisory role for |
Wellcome Animal Health/Coopers Animal Health. Before joining the industry, Dr. Gunn spent nine years as a veterinarian, first as a practicing veterinarian working with companion and farm animals and then as a veterinary adviser for the British Ministry of Agriculture. Dr. Gunn is a member of the Royal College of Veterinary Surgeons in the UK, and in 2008, Dr. Gunn received an honorary doctorate in Veterinary Medicine and Surgery from the University of Edinburgh. Dr. Gunn holds a Bachelor of Veterinary Medicine and Surgery and a Post Graduate Diploma in Veterinary State Medicine, both from the Royal Dick School of Veterinary Studies in Edinburgh, UK. Dr. Gunn serves on the Boards of Directors of Diversigen, Inc., which provides comprehensive microbiome and metagenomics services, Nuritas Ltd, which develops active ingredients for human and animal health, Sidai Ltd, which aims to establish livestock services centers in Kenya that provide animal health products and veterinary services to livestock producers, and ViroVet | |
Name | | | Age | | | Principal Occupation and Business Experience | |
| | | | | | BVBA, a biopharmaceutical company that seeks to develop innovative technologies to improve the health and value of livestock. Dr. Gunn previously served on the boards of directors of Vericore Holdings Ltd., Nexvet Biopharma plc, Pharmaq AS and Animalcare Group plc. Dr. Gunn is qualified to serve on our Board of Directors due to his substantial management experience, executive leadership and deep knowledge and understanding of the animal health industry. | |
Name | | | Age | | | Principal Occupation and Business Experience | |
Daniel M. Bendheim | | | | | Mr. Bendheim serves as a member of our Board of Directors and is our Executive Vice President, Corporate Strategy. Mr. Bendheim joined us in 1997. He was appointed Vice President of Business Development in 2001 and was later appointed President, Performance Products in 2004, and then Executive Vice President, Corporate Strategy in March 2014. He was elected as a director of Phibro in November 2013. Prior to joining us, Mr. Bendheim worked as an analyst at South Coast Capital, a boutique investment bank. Mr. Bendheim obtained a B.A. degree in political science with honors from Yeshiva University in 1993 and a J.D. degree with honors from Harvard Law School in 1996. Mr. Bendheim is a son of Jack C. Bendheim and, together with certain other family members, is a manager of BFI with respect to certain economic rights pertaining to shares of our stock owned by BFI. Mr. Bendheim is qualified to serve on our Board of Directors due to his extensive management experience in all facets of the animal health, mineral nutrition and performance products businesses during his tenure with the Company and his management role within BFI. | | |
Jonathan Bendheim | | | | | Mr. Bendheim serves as a member of our Board of Directors and is President of our MACIE Region (which consists of the Middle East, Africa, the Commonwealth of Independent States, India and Europe), is the general manager of our operating plants in Israel and Ireland, and oversees Phibro’s global aquaculture business. Mr. Bendheim joined Phibro in 2001 as a Manager for logistics and supply chain. In 2005, Mr. Bendheim was appointed Vice President of Sales and Business Development for our Israel operations. In 2008, he led the acquisition of Abic Biological Laboratories from Teva, and in 2009, he was appointed the Managing Director of our operations in Israel. In 2011, his |
responsibilities were expanded to include oversight of all sales activities in the MACIE Region. In 2014, Jonathan led the establishment of Phibro’s global aquaculture business. Mr. Bendheim holds a B.A. degree in political science from Yeshiva University and an MBA from Columbia Business School. Mr. Bendheim is a son of Jack C. Bendheim. Mr. Bendheim is qualified to serve on our Board of Directors due to his extensive management experience in all facets of Phibro’s animal health and nutrition businesses during his tenure with the Company. | | ||||||
Sam Gejdenson | | | | | Mr. Gejdenson has been a director of Phibro since January 2004 and is a member of our Audit Committee and our Compensation Committee. Mr. Gejdenson is the Chairman of our Compensation Committee. Since 2001, Mr. Gejdenson has been involved in international trade through his own company, Sam Gejdenson International, where he has worked with various multi-national clients on projects in Europe, Asia and Africa. | |
Name | | | Age | | | Principal Occupation and Business Experience | |
| | | | | | Mr. Gejdenson presently serves on the | |
Name | | | Age | | | Principal Occupation and Business Experience | |
Gerald K. Carlson | | | 76 | | | Mr. Carlson serves as a member of our Board of Directors and was our Chief Operating Officer from March 2014 until June 2016. Mr. Carlson joined us as Chief Executive Officer in May 2002 and served in that position until his appointment as Chief Operating Officer. He has been a director since 2008. Prior to joining us, Mr. Carlson served as the Commissioner of Trade and Development for the State of Minnesota from 1999 to 2001. Prior to his retirement in 1998 after a thirty-two year career at Ecolab Inc., a global provider of cleaning and sanitation products, systems and services, Mr. Carlson served as Senior Vice President — Corporate Planning and Development, Senior Vice President of International and Senior Vice President and General Manager — Institutional North America. Mr. Carlson is qualified to serve on our Board of Directors due to his broad experience and track record in leading and building businesses, and his strong background in corporate strategy and business development. | |
Mary Lou Malanoski | | | 62 | | | Ms. Malanoski has been a director since May 2004. Ms. Malanoski is the Chief Financial Officer of S2K Financial Partners Holdings Co. LLC and was the Chief Financial Officer of its predecessor entities, S2K Financial Holdings LLC and S2K Partners Holdings LLC, beginning in April 2016. Previously, Ms. Malanoski was an independent financial consultant from April 2015 until March 2016 and served as the acting Chief Financial Officer of Nina McLemore, LLC from June 2015 until December 2015. Ms. Malanoski served as Vice Chair and Chief Operating Officer at Morgan Joseph TriArtisan Group, Inc., an investment bank focused on mid-market companies, from March 2012 to March 2015. She joined Morgan Joseph TriArtisan Group, Inc. in July 2001 as a Managing Director and Chief Financial Officer, became Co-Head of Investment Banking in 2008, and served as Head of Investment Banking from March 2009 through March 2012. Ms. Malanoski has also served on the board of directors of Morgan Joseph TriArtisan Group, Inc. since 2008. From 1994 until 2001, Ms. Malanoski served as Managing Director and Chief Financial Officer of New Street Advisors LP, a private equity firm that she co-founded. Prior to 1994, Ms. Malanoski was a Managing Director at New Street Capital, the successor to the reorganized Drexel Burnham Lambert, where she began her career in the Corporate Finance Department. Ms. Malanoski serves on the board of directors and is a | |
Name | | | Age | | | Principal Occupation and Business Experience | |
| | | | | | member of the audit committee of Getty Realty Corp., a real estate investment trust specializing in convenience stores, gasoline stations and related properties. In addition to her understanding of our business from her service on our Board of Directors, Ms. Malanoski brings to our Board substantial management, finance and investment banking experience. | |
Carol A. Wrenn | | | 58 | | | Ms. Wrenn has been a director since July 2010. Ms. Wrenn also serves as a member of the Audit Committee and the Compensation Committee. She is the founder and owner of Whitewater Advisors LLC, which provides consulting services to small businesses and 50% owner of Aurora Borealis LLC, which operates online retail businesses. She was the founder and owner of Sky River Helicopters, LLC, a company that provides helicopter charters, tours, commercial services and lessons, from January 2010 until September 2015. She previously served as an Executive Vice President and the President of the Animal Health Division at Alpharma Inc., a human and animal pharmaceutical company, from November 2001 to June 2009. From April 2007 to April 2009, Ms. Wrenn also held the position of Chairman of the Animal Health Institute, an industry organization advocating for animal health issues, including efficient and effective FDA, USDA and EPA regulatory and approval processes. From January 2002 to June 2009, she was an active member of the board of directors of the International Federation of Animal Health. Prior to joining Alpharma, Ms. Wrenn held various executive positions at Honeywell International Inc. (formerly, AlliedSignal Inc.) from 1984 to 2001. She served as Business Director of Honeywell’s Refrigerants, Fluorine Products Division from 2000 to 2001 and was the Commercial Director and Managing Director of Honeywell’s European Fluorochemical operations based in Haasrode, Belgium from 1997 to 2000. Ms. Wrenn also held a number of positions in sales, marketing, business development and finance during her tenure with AlliedSignal. Ms. Wrenn served as a director of Heska Corporation from January 2013 until May 2019. She holds a Bachelor’s Degree from Union College, an MBA from Lehigh University and a DBA from California Southern University. Ms. Wrenn is qualified to serve on our Board of Directors due to her relevant industry experience, strategic and problem-solving skills and strong interpersonal and negotiation skills. | |
| | 2018 | | 2017 | | | 2019 | | 2018 | | ||||||||||||||||
| | (In Thousands) | | | (In Thousands) | | ||||||||||||||||||||
Audit Fees(1) | | | $ | 3,470 | | | | $ | 3,003 | | | | | $ | 4,877 | | | | $ | 3,470 | | | ||||
Audit-Related Fees(2) | | | | — | | | | | — | | | | | | — | | | | | — | | | ||||
Tax Fees(3) | | | | 177 | | | | | 50 | | | | | | 230 | | | | | 177 | | | ||||
All Other Fees(4) | | | | 62 | | | | | 4 | | | | | | 6 | | | | | 62 | | | ||||
Total Fees | | | $ | 3,709 | | | | $ | 3,057 | | | | | $ | 5,113 | | | | $ | 3,709 | | | ||||
|
Name | | | Fees earned or paid in cash | | | Stock awards | | | Option awards | | | Non-equity incentive plan compensation | | | Nonqualified deferred compensation earnings | | | All other compensation | | | Total | | |||||||||||||||||||||
Gerald K. Carlson | | | | $ | 40,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | $ | 40,000 | | |
E. Thomas Corcoran | | | | | 50,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 50,000 | | |
Sam Gejdenson | | | | | 60,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 60,000 | | |
Dr. George Gunn | | | | | 50,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 50,000 | | |
Mary Lou Malanoski | | | | | 40,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 40,000 | | |
Carol A. Wrenn | | | | | 60,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 60,000 | | |
Name | | | Age | | | Position | |
Jack C. Bendheim | | | | | Chairman of the Board of Directors, President and Chief Executive Officer | | |
Larry L. Miller | | | | | Chief Operating Officer | | |
Richard G. Johnson | | | | | Chief Financial Officer | | |
Daniel M. Bendheim | | | | | Director and Executive Vice President, Corporate Strategy | | |
Thomas G. Dagger | | | | | Senior Vice President, General Counsel and Corporate Secretary | | |
Anthony Andolino | | | | | Vice President Finance and Treasurer | | |
Rob Aukerman | | | 61 | | | President, North America Region | |
Dean J. Warras | | | | | Senior Vice President, | | |
Lisa A. Escudero | | | | | Senior Vice President, Human Resources | |
Name | | | Position | |
Jack C. Bendheim | | | Chairman, President and Chief Executive Officer | |
Richard G. Johnson | | | Chief Financial Officer | |
Larry L. Miller | | | Chief Operating Officer | |
Dean Warras | | | Senior Vice President, Strategic Alliances | |
Thomas G. Dagger | | | Senior Vice President, General Counsel & Corporate Secretary | |
Compensation Component | | | Link to Business and Talent Strategies | | | Fiscal year ended June 30, 2019 Compensation Actions | |
Base Salary (Page 26) | | | • Competitive base salaries help attract and retain executive talent. | | | • Merit based increases for the fiscal year ended June 30, 2019, ranging from 2.5% to 6.4% for the NEOs other than the CEO. Our CEO did not receive a salary increase for the fiscal year ended June 30, 2019. | |
Incentive Compensation (Page 26) | | | • Focus executives on achieving financial results that are key indicators of ongoing operational performance that are expected to drive stockholder value creation. | | | • Annual cash incentive awards based on pre-determined financial performance criteria were not earned for the fiscal year ended June 30, 2019, however, discretionary bonuses were paid to certain NEOs as discussed below. | |
| Compensation Committee | | | • Establishes executive compensation philosophy • Approves incentive compensation programs and performance goals for the annual management incentive plan (MIP) • Approves all compensation actions for the named executive officers • Independent committee members approve all compensation actions for the CEO outside of the CEO’s presence | |
| CEO and Management | | | • Management, including the CEO, develops preliminary recommendations regarding compensation matters with respect to all NEOs, other than the CEO, and provides these recommendations to the Compensation Committee, which makes the final decisions • Responsible for the administration of the compensation programs once Compensation Committee decisions are finalized • CEO is not involved in any decision as to his own compensation | |
| | | Fiscal year ended June 30, 2018 Base Salary | | | Increase (%) | | | Fiscal year ended June 30, 2019 Base Salary | | |||||||||
Jack C. Bendheim | | | | $ | 2,065,500 | | | | | | — | | | | | $ | 2,065,500 | | |
Richard G. Johnson | | | | $ | 448,100 | | | | | | 3.8% | | | | | $ | 465,000 | | |
Larry L. Miller | | | | $ | 566,500 | | | | | | 5.9% | | | | | $ | 600,000 | | |
Dean Warras | | | | $ | 432,600 | | | | | | 2.5% | | | | | $ | 443,400 | | |
Thomas G. Dagger | | | | $ | 376,000 | | | | | | 6.4% | | | | | $ | 400,000 | | |
| | | Fiscal year ended June 30, 2019 Target Annual Incentive as Percent of Base Salary (%) | | | Fiscal year ended June 30, 2019 Target Annual Incentive ($) | | ||||||
Jack C. Bendheim | | | | | 50% | | | | | $ | 1,032,750 | | |
Richard G. Johnson | | | | | 50% | | | | | $ | 232,500 | | |
Larry L. Miller | | | | | 50% | | | | | $ | 300,000 | | |
Dean Warras | | | | | 50% | | | | | $ | 221,700 | | |
Thomas G. Dagger | | | | | 50% | | | | | $ | 200,000 | | |
Metric | | | Weighting | | | Rationale for Metric | | | Payout Range | |
Sales | | | 25% | | | Sales are reflective of top line performance and a key metric for our investors | | | 50% – 150% | |
Adjusted EBITDA | | | 75% | | | Earnings before Interest, Taxes, Depreciation and Amortization, adjusted for certain items including restructuring and acquisition related items, stock-based compensation costs and other unusual or non-operational items (Adjusted EBITDA) is reflective of our operating performance and a key metric for our investors | | | 50% – 150% | |
| | | Threshold | | | Target | | | Maximum | | | Actual | | | % of Target Achieved | | | Payout % | | ||||||||||||||||||
Payout % | | | | | 50% | | | | | | 100% | | | | | | 150% | | | | | | |||||||||||||||
Sales ($ millions) | | | | $ | 845 | | | | | $ | 893 | | | | | $ | 915 | | | | | $ | 828 | | | | | | 0% | | | | | | 0% | | |
Adjusted EBITDA ($ millions) | | | | $ | 124 | | | | | $ | 130 | | | | | $ | 136 | | | | | $ | 118 | | | | | | 0% | | | | | | 0% | | |
Weighted Average Payout: 0% | |
| | | Target Annual Incentive Opportunity | | | Financial Performance Target Payout % | | | Annual Cash Incentive Payout | | | % of Target | | | Discretionary Bonus Payout | | |||||||||||||||
Jack C. Bendheim | | | | $ | 1,032,750 | | | | | | 100% | | | | | $ | — | | | | | | 0% | | | | | $ | — | | |
Richard G. Johnson | | | | $ | 232,500 | | | | | | 100% | | | | | $ | — | | | | | | 0% | | | | | $ | — | | |
Larry L. Miller | | | | $ | 300,000 | | | | | | 100% | | | | | $ | — | | | | | | 0% | | | | | $ | — | | |
Dean Warras | | | | $ | 221,700 | | | | | | 80% | | | | | $ | 44,300 | | | | | | 20% | | | | | $ | 22,180 | | |
Thomas Dagger | | | | $ | 200,000 | | | | | | 100% | | | | | $ | — | | | | | | 0% | | | | | $ | 60,000 | | |
Name and principal position(1) | | Year | | Salary(2) | | Bonus | | Stock Awards | | Option Awards(3) | | Change in Pension Value and Nonqualified Deferred Compensation(4) | | All Other Compensation(5) | | Total | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jack C. Bendheim Chairman of the Board, President and Chief Executive Officer | | | | | 2018 | | | | $ | 2,065,500 | | | | $ | 1,056,000 | | | | $ | — | | | | $ | — | | | | $ | 14,615 | | | | $ | 176,067 | | | | $ | 3,312,182 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2017 | | | | | 2,025,000 | | | | | 762,000 | | | | | — | | | | | — | | | | | 161,794 | | | | | 245,838 | | | | | 3,194,632 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2016 | | | | | 1,966,400 | | | | | 578,500 | | | | | — | | | | | — | | | | | 251,857 | | | | | 152,162 | | | | | 2,948,919 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Name and Principal Position | | Fiscal Year | | Salary ($) | | Bonus ($) | | Stock Awards ($) | | Non-Equity Incentive Plan Compensation ($) | | Change in Pension Value and Nonqualified Deferred Compensation Earnings ($)(5) | | All Other Compensation ($)(6) | | Total ($) | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jack C. Bendheim Chairman of the Board, President, and Chief Executive Officer(1) | | | | | 2019 | | | | $ | 2,065,500 | | | | $ | — | | | | $ | — | | | | $ | — | | | | $ | 476,748 | | | | $ | 178,981 | | | | $ | 2,721,229 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2018 | | | | $ | 2,065,500 | | | | $ | — | | | | $ | — | | | | $ | 1,056,000 | | | | $ | 103,444 | | | | $ | 185,387 | | | | $ | 3,410,331 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2017 | | | | $ | 2,025,000 | | | | $ | — | | | | $ | — | | | | $ | 762,000 | | | | $ | 20,280 | | | | $ | 245,838 | | | | $ | 3,053,118 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Richard G. Johnson Chief Financial Officer | | | | | 2019 | | | | $ | 465,000 | | | | $ | — | | | | $ | — | | | | $ | — | | | | $ | 145,988 | | | | $ | 42,996 | | | | $ | 653,984 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2018 | | | | $ | 448,100 | | | | $ | — | | | | $ | — | | | | $ | 229,000 | | | | $ | — | | | | $ | 42,456 | | | | $ | 719,556 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2017 | | | | $ | 435,000 | | | | $ | — | | | | $ | — | | | | $ | 200,000 | | | | $ | 46,475 | | | | $ | 35,759 | | | | $ | 717,234 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Larry L. Miller Chief Operating Officer | | | | | 2018 | | | | | 566,500 | | | | | 289,500 | | | | | 5,981,000(6) | | | | | — | | | | | (6,537) | | | | | 27,057 | | | | | 6,857,520 | | | | | | | 2019 | | | | $ | 600,000 | | | | $ | — | | | | $ | — | | | | $ | — | | | | $ | 44,103 | | | | $ | 26,460 | | | | $ | 670,563 | | | ||||||||||||||
| | | 2017 | | | | | 550,000 | | | | | 208,000 | | | | | — | | | | | — | | | | | 3,237 | | | | | 29,906 | | | | | 791,143 | | | | | | 2018 | | | | $ | 566,500 | | | | $ | — | | | | $ | 5,981,000(4) | | | | $ | 289,500 | | | | $ | — | | | | $ | 27,057 | | | | $ | 6,864,057 | | | |||||||||||||||||
| | | 2016 | | | | | 457,700 | | | | | 195,000 | | | | | — | | | | | — | | | | | 68,559 | | | | | 19,437 | | | | | 740,696 | | | | | | 2017 | | | | $ | 550,000 | | | | $ | — | | | | $ | — | | | | $ | 208,000 | | | | $ | 3,237 | | | | $ | 29,906 | | | | $ | 791,143 | | | |||||||||||||||||
Dean J. Warras President, Animal Health & Nutrition, North America | | | | | 2018 | | | | | 432,600 | | | | | 466,400(8) | | | | | — | | | | | | | | | | (4,787) | | | | | 24,977 | | | | | 919,190 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2017 | | | | | 420,000 | | | | | 639,000(9) | | | | | — | | | | | — | | | | | (8,602) | | | | | 25,861 | | | | | 1,076,259 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2016(7) | | | | | 326,100 | | | | | 330,350(10) | | | | | — | | | | | — | | | | | 73,169 | | | | | 7,731 | | | | | 737,350 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dean Warras President, Animal Health & Nutrition, North America | | | | | 2019 | | | | $ | 443,400 | | | | $ | 272,180(2) | | | | $ | — | | | | $ | 44,300 | | | | $ | 46,345 | | | | $ | 26,015 | | | | $ | 832,240 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2018 | | | | $ | 432,600 | | | | $ | 250,000(2) | | | | $ | — | | | | $ | 216,400 | | | | $ | — | | | | $ | 24,977 | | | | $ | 923,977 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2017 | | | | $ | 420,000 | | | | $ | 420,000(2) | | | | $ | — | | | | $ | 219,000 | | | | $ | — | | | | $ | 25,861 | | | | $ | 1,084,861 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thomas G. Dagger Senior V.P., General Counsel, and Corporate Secretary | | | | | 2019 | | | | $ | 400,000 | | | | $ | 60,000(3) | | | | $ | — | | | | $ | — | | | | $ | 63,788 | | | | $ | 40,277 | | | | $ | 564,065 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2018 | | | | $ | 376,000 | | | | $ | — | | | | $ | — | | | | $ | 192,200 | | | | $ | — | | | | $ | 39,997 | | | | $ | 608,197 | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | 2017 | | | | $ | 365,000 | | | | $ | — | | | | $ | — | | | | $ | 137,000 | | | | $ | 25,467 | | | | $ | 32,195 | | | | $ | 559,662 | | |
Name | | | Year | | | Automobile Allowance | | | 401(k) Plan Company Match | | | Group Term Life Insurance | | | Tax Planning Services | | | Legal Services | | | Accounting Services | | | Total | | ||||||||||||||||||||||||
Jack C. Bendheim | | | | | 2019 | | | | | $ | — | | | | | $ | 16,684 | | | | | $ | 6,489 | | | | | $ | 107,597 | | | | | $ | 17,432 | | | | | $ | 30,778 | | | | | $ | 178,981 | | |
| | | 2018 | | | | | $ | — | | | | | $ | 28,341 | | | | | $ | 8,652 | | | | | $ | 58,661 | | | | | $ | 32,733 | | | | | $ | 57,000 | | | | | $ | 185,387 | | | ||
| | | 2017 | | | | | $ | — | | | | | $ | 28,120 | | | | | $ | 6,993 | | | | | $ | 127,560 | | | | | $ | 26,164 | | | | | $ | 57,000 | | | | | $ | 245,838 | | | ||
Richard G. Johnson | | | | | 2019 | | | | | $ | 9,000 | | | | | $ | 27,003 | | | | | $ | 6,993 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 42,996 | | |
| | | 2018 | | | | | $ | 9,000 | | | | | $ | 28,122 | | | | | $ | 5,334 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 42,456 | | | ||
| | | 2017 | | | | | $ | 6,750 | | | | | $ | 23,675 | | | | | $ | 5,334 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 35,759 | | | ||
Larry L. Miller | | | | | 2019 | | | | | $ | — | | | | | $ | 24,654 | | | | | $ | 1,806 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 26,460 | | |
| | | 2018 | | | | | $ | — | | | | | $ | 25,671 | | | | | $ | 1,386 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 27,057 | | | ||
| | | 2017 | | | | | $ | 1,875 | | | | | $ | 27,065 | | | | | $ | 966 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 29,906 | | | ||
Dean Warras | | | | | 2019 | | | | | $ | — | | | | | $ | 25,217 | | | | | $ | 798 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 26,015 | | |
| | | 2018 | | | | | $ | — | | | | | $ | 24,347 | | | | | $ | 630 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 24,977 | | | ||
| | | 2017 | | | | | $ | — | | | | | $ | 25,231 | | | | | $ | 630 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 25,861 | | | ||
Thomas G. Dagger | | | | | 2019 | | | | | $ | 9,000 | | | | | $ | 28,505 | | | | | $ | 2,772 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 40,277 | | |
| | | 2018 | | | | | $ | 9,000 | | | | | $ | 28,708 | | | | | $ | 2,289 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 39,997 | | | ||
| | | 2017 | | | | | $ | 9,000 | | | | | $ | 21,389 | | | | | $ | 1,806 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 32,195 | | |
Name | | | Year | | | Automobile Allowance | | | 401(k) Plan Company Match | | | Group Term Life Insurance | | | Tax Planning Services | | | Legal Services | | | Accounting Services | | | Total | | ||||||||||||||||||||||||
Jack C. Bendheim | | | | | 2019 | | | | | $ | — | | | | | $ | 16,684 | | | | | $ | 6,489 | | | | | $ | 107,597 | | | | | $ | 17,432 | | | | | $ | 30,778 | | | | | $ | 178,981 | | |
| | | 2018 | | | | | $ | — | | | | | $ | 28,341 | | | | | $ | 8,652 | | | | | $ | 58,661 | | | | | $ | 32,733 | | | | | $ | 57,000 | | | | | $ | 185,387 | | | ||
| | | 2017 | | | | | $ | — | | | | | $ | 28,120 | | | | | $ | 6,993 | | | | | $ | 127,560 | | | | | $ | 26,164 | | | | | $ | 57,000 | | | | | $ | 245,838 | | | ||
Richard G. Johnson | | | | | 2019 | | | | | $ | 9,000 | | | | | $ | 27,003 | | | | | $ | 6,993 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 42,996 | | |
| | | 2018 | | | | | $ | 9,000 | | | | | $ | 28,122 | | | | | $ | 5,334 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 42,456 | | | ||
| | | 2017 | | | | | $ | 6,750 | | | | | $ | 23,675 | | | | | $ | 5,334 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 35,759 | | | ||
Larry L. Miller | | | | | 2019 | | | | | $ | — | | | | | $ | 24,654 | | | | | $ | 1,806 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 26,460 | | |
| | | 2018 | | | | | $ | — | | | | | $ | 25,671 | | | | | $ | 1,386 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 27,057 | | | ||
| | | 2017 | | | | | $ | 1,875 | | | | | $ | 27,065 | | | | | $ | 966 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 29,906 | | | ||
Dean Warras | | | | | 2019 | | | | | $ | — | | | | | $ | 25,217 | | | | | $ | 798 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 26,015 | | |
| | | 2018 | | | | | $ | — | | | | | $ | 24,347 | | | | | $ | 630 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 24,977 | | | ||
| | | 2017 | | | | | $ | — | | | | | $ | 25,231 | | | | | $ | 630 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 25,861 | | | ||
Thomas G. Dagger | | | | | 2019 | | | | | $ | 9,000 | | | | | $ | 28,505 | | | | | $ | 2,772 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 40,277 | | |
| | | 2018 | | | | | $ | 9,000 | | | | | $ | 28,708 | | | | | $ | 2,289 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 39,997 | | | ||
| | | 2017 | | | | | $ | 9,000 | | | | | $ | 21,389 | | | | | $ | 1,806 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 32,195 | | |
Name | | | Year | | | Automobile Allowance | | | 401(k) Plan Company Match | | | Group Term Life Insurance | | | Tax Planning Services | | | Legal Services | | | Accounting Services | | | Total | | ||||||||||||||||||||||||
Jack C. Bendheim | | | | | 2019 | | | | | $ | — | | | | | $ | 16,684 | | | | | $ | 6,489 | | | | | $ | 107,597 | | | | | $ | 17,432 | | | | | $ | 30,778 | | | | | $ | 178,981 | | |
| | | 2018 | | | | | $ | — | | | | | $ | 28,341 | | | | | $ | 8,652 | | | | | $ | 58,661 | | | | | $ | 32,733 | | | | | $ | 57,000 | | | | | $ | 185,387 | | | ||
| | | 2017 | | | | | $ | — | | | | | $ | 28,120 | | | | | $ | 6,993 | | | | | $ | 127,560 | | | | | $ | 26,164 | | | | | $ | 57,000 | | | | | $ | 245,838 | | | ||
Richard G. Johnson | | | | | 2019 | | | | | $ | 9,000 | | | | | $ | 27,003 | | | | | $ | 6,993 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 42,996 | | |
| | | 2018 | | | | | $ | 9,000 | | | | | $ | 28,122 | | | | | $ | 5,334 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 42,456 | | | ||
| | | 2017 | | | | | $ | 6,750 | | | | | $ | 23,675 | | | | | $ | 5,334 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 35,759 | | | ||
Larry L. Miller | | | | | 2019 | | | | | $ | — | | | | | $ | 24,654 | | | | | $ | 1,806 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 26,460 | | |
| | | 2018 | | | | | $ | — | | | | | $ | 25,671 | | | | | $ | 1,386 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 27,057 | | | ||
| | | 2017 | | | | | $ | 1,875 | | | | | $ | 27,065 | | | | | $ | 966 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 29,906 | | | ||
Dean Warras | | | | | 2019 | | | | | $ | — | | | | | $ | 25,217 | | | | | $ | 798 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 26,015 | | |
| | | 2018 | | | | | $ | — | | | | | $ | 24,347 | | | | | $ | 630 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 24,977 | | | ||
| | | 2017 | | | | | $ | — | | | | | $ | 25,231 | | | | | $ | 630 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 25,861 | | | ||
Thomas G. Dagger | | | | | 2019 | | | | | $ | 9,000 | | | | | $ | 28,505 | | | | | $ | 2,772 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 40,277 | | |
| | | 2018 | | | | | $ | 9,000 | | | | | $ | 28,708 | | | | | $ | 2,289 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 39,997 | | | ||
| | | 2017 | | | | | $ | 9,000 | | | | | $ | 21,389 | | | | | $ | 1,806 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 32,195 | | |
Name | | | Year | | | 401(k) Plan Company Contributions(1) | | | Other(2) | | | Total | | ||||||||||||
Jack C. Bendheim | | | | | 2018 | | | | | $ | 28,341 | | | | | $ | 147,726 | | | | | $ | 176,067 | | |
| | | 2017 | | | | | | 28,120 | | | | | | 217,717 | | | | | | 245,838 | | | ||
| | | 2016 | | | | | | — | | | | | | 152,162 | | | | | | 152,162 | | | ||
Larry L. Miller | | | | | 2018 | | | | | | 25,671 | | | | | | 1,386 | | | | | | 27,057 | | |
| | | 2017 | | | | | | 27,065 | | | | | | 2,841 | | | | | | 29,906 | | | ||
| | | 2016 | | | | | | 9,471 | | | | | | 9,966 | | | | | | 19,437 | | | ||
Dean J. Warras | | | | | 2018 | | | | | | 24,347 | | | | | | 630 | | | | | | 24,977 | | |
| | | 2017 | | | | | | 25,231 | | | | | | 630 | | | | | | 25,861 | | | ||
| | | 2016 | | | | | | 7,101 | | | | | | 630 | | | | | | 7,731 | | |
Option Awards | | | Stock Awards | | |||||||||||||||||||||||||||||||||||||||||||||
Name | | | Number of Securities Underlying Unexercised options (exercisable) | | | Number of Securities Underlying Unexercised options (unexercisable) | | | Option Exercise Price | | | Option Expiration Date | | | Number of Shares or Units of Stock that Have Not Vested | | | Market Value of Shares or Units of Stock That Have Not Vested | | | Number of Unearned Shares, Units or Other Rights That Have Not Vested(1) | | | Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested(2) | | ||||||||||||||||||||||||
Jack C. Bendheim | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Larry L. Miller | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 250,000 | | | | | $ | 5,544,788 | | |
Dean J. Warras | | | | | 41,560 | | | | | | — | | | | | $ | 11.83 | | | | February 28, 2019 | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | | | | | Estimated Future Payouts Under Non-Equity Incentive Plans(1) | | |||||||||||||||
Name | | | Grant Date | | | Threshold ($) | | | Target ($) | | | Maximum ($) | | ||||||||||||
Jack C. Bendheim | | | | | — | | | | | $ | 516,375 | | | | | $ | 1,032,750 | | | | | $ | 1,549,125 | | |
Richard G. Johnson | | | | | — | | | | | $ | 116,250 | | | | | $ | 232,500 | | | | | $ | 348,750 | | |
Larry L. Miller | | | | | — | | | | | $ | 150,000 | | | | | $ | 300,000 | | | | | $ | 450,000 | | |
Dean Warras | | | | | — | | | | | $ | 110,850 | | | | | $ | 221,700 | | | | | $ | 332,550 | | |
Thomas G. Dagger | | | | | — | | | | | $ | 100,000 | | | | | $ | 200,000 | | | | | $ | 300,000 | | |
| | | Stock Awards | | |||||||||||||||||||||
Name | | | Number of Shares or Units of Stock That Have Not Yet Vested (#) | | | Market Value of Shares or Units of Stock That Have Not Yet Vested ($)(1) | | | Equity Incentive Plan Awards: Number of Unearned Shares, Units, or Other Rights That Have Not Yet Vested (#) | | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares Units, or Other Rights That Have Not Yet Vested ($)(1) | | ||||||||||||
Jack C. Bendheim | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Richard G. Johnson | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Larry L. Miller | | | | | 50,000(2) | | | | | $ | 1,588,500 | | | | | | 200,000(3) | | | | | $ | 6,354,000(3) | | |
Dean Warras | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Thomas G. Dagger | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | Option Awards | | | Stock Awards | | ||||||||||||||||||
Name | | | Number of Shares Acquired on Exercise (#) | | | Value Realized on Exercise ($) | | | Number of Shares Acquired on Vesting (#) | | | Value Realized on Vesting ($) | | ||||||||||||
Jack C. Bendheim | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Richard G. Johnson | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Larry L. Miller | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Dean Warras | | | | | 41,560 | | | | | $ | 1,084,972 | | | | | | — | | | | | | — | | |
Thomas G. Dagger | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Name | | | Plan | | | Number of Years Credited Service (#)(1) | | | Present Value of Accumulated Benefit ($)(2) | | | Payments During Last Fiscal Year ($) | | |||||||||
Jack C. Bendheim | | | Pension Plan | | | | | 25.08 | | | | | $ | 1,289,849 | | | | | $ | — | | |
| | | Retirement Income Plan | | | | | 29.35 | | | | | $ | 1,623,735 | | | | | $ | — | | |
| | | Executive Income Program | | | | | 25.30 | | | | | $ | 327,651 | | | | | $ | — | | |
Richard G. Johnson | | | Pension Plan | | | | | 14.00 | | | | | $ | 853,218 | | | | | $ | — | | |
| | | Retirement Income Plan | | | | | N/A | | | | | $ | — | | | | | $ | — | | |
| | | Executive Income Program | | | | | N/A | | | | | $ | — | | | | | $ | — | | |
Larry L. Miller | | | Pension Plan | | | | | 8.33 | | | | | $ | 279,915 | | | | | $ | — | | |
| | | Retirement Income Plan | | | | | N/A | | | | | $ | — | | | | | $ | — | | |
| | | Executive Income Program | | | | | N/A | | | | | $ | — | | | | | $ | — | | |
Dean Warras | | | Pension Plan | | | | | 11.08 | | | | | $ | 285,803 | | | | | $ | — | | |
| | | Retirement Income Plan | | | | | N/A | | | | | $ | — | | | | | $ | — | | |
| | | Executive Income Program | | | | | N/A | | | | | $ | — | | | | | $ | — | | |
Thomas G. Dagger | | | Pension Plan | | | | | 9.83 | | | | | $ | 416,149 | | | | | $ | — | | |
| | | Retirement Income Plan | | | | | N/A | | | | | $ | — | | | | | $ | — | | |
| | | Executive Income Program | | | | | N/A | | | | | $ | — | | | | | $ | — | | |
Name | | | Executive Contributions In Last FY ($) | | | Company Contributions In Last FY ($) | | | Aggregate Earnings In Last FY ($) | | | Aggregate Withdrawals/ Distributions ($) | | | Aggregate Balance At Last FYE ($) | | |||||||||||||||
Jack C. Bendheim | | | | $ | — | | | | | $ | — | | | | | $ | 62,414(1) | | | | | $ | — | | | | | $ | 1,046,487(2) | | |
Richard G. Johnson | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Larry L. Miller | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Dean Warras | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Thomas G. Dagger | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | | Prior to Change in Control | | | After Change in Control | | | | | |||||||||||||||||||||||||||||||||
Name | | | Type of Payment | | | Good Reason Termination ($)(1) | | | Involuntary Termination Without Cause ($) | | | Good Reason Termination ($)(1) | | | Involuntary Termination Without Cause ($) | | | Involuntary Termination With Cause ($) | | | Death ($) | | | Disability ($) | | |||||||||||||||||||||
Jack C. Bendheim | | | Cash Severance(2) | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 1,032,750 | | | | | $ | 1,032,750 | | |
| | | Healthcare Coverage(3) | | | | $ | 34,623 | | | | | $ | 34,623 | | | | | $ | 34,623 | | | | | $ | 34,623 | | | | | $ | — | | | | | $ | — | | | | | $ | 23,046 | | |
| | | Equity Incentives | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Long-Term Cash | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Car Allowance | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Total | | | | $ | 34,623 | | | | | $ | 34,623 | | | | | $ | 34,623 | | | | | $ | 34,623 | | | | | $ | — | | | | | $ | 1,032,750 | | | | | $ | 1,055,796 | | |
Richard G. Johnson | | | Cash Severance | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Healthcare Coverage | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Equity Incentives | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Long-Term Cash | | | | $ | 4,548,714(4) | | | | | $ | 5,500,000(4) | | | | | $ | 5,500,000(5) | | | | | $ | 5,500,000(5) | | | | | $ | 4,400,000 | | | | | $ | 5,500,000(5) | | | | | $ | 5,500,000(5) | | |
| | | Car Allowance | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Total | | | | $ | 4,548,714 | | | | | $ | 5,500,000 | | | | | $ | 5,500,000 | | | | | $ | 5,500,000 | | | | | $ | 4,400,000 | | | | | $ | 5,500,000 | | | | | $ | 5,500,000 | | |
Larry L. Miller | | | Cash Severance(6) | | | | $ | 600,000 | | | | | $ | 600,000 | | | | | $ | 600,000 | | | | | $ | 600,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Healthcare Coverage | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Equity Incentives | | | | $ | 2,602,122(7) | | | | | $ | 2,602,122(7) | | | | | $ | 7,942,500(8) | | | | | $ | 7,942,500(8) | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Long-Term Cash | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Car Allowance | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Total | | | | $ | 3,202,122 | | | | | $ | 3,202,122 | | | | | $ | 8,542,500 | | | | | $ | 8,542,500 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Dean Warras | | | Cash Severance | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Healthcare Coverage | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Equity Incentives | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Long-Term Cash | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Car Allowance | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Total | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Thomas G. Dagger | | | Cash Severance(9) | | | | $ | 500,000 | | | | | $ | 500,000 | | | | | $ | 500,000 | | | | | $ | 500,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Healthcare Coverage(10) | | | | $ | 34,416 | | | | | $ | 34,416 | | | | | $ | 34,416 | | | | | $ | 34,416 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Equity Incentives | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Long-Term Cash | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Car Allowance(11) | | | | $ | 9,000 | | | | | $ | 9,000 | | | | | $ | 9,000 | | | | | $ | 9,000 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | | Total | | | | $ | 543,416 | | | | | $ | 543,416 | | | | | $ | 543,416 | | | | | $ | 543,416 | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Name and Address of Beneficial Owner(1) | | | Number of shares beneficially owned | | Percentage of class owned | | | Percentage total equity interest(2) | | Percentage total voting power(3) | | | | Number of Shares Beneficially Wwned | | Percentage of Class Owned | | | Percentage Total Equity Interest(2) | | Percentage Total Voting Power(3) | | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Class A | | Class B | | Class A | | Class B | | | Class A | | Class B | | Class A | | Class B | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5% Stockholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||
BFI Co., LLC(4) | | | | 59,480 | | | | | 20,166,034 | | | | | * | | | | | 100% | | | | | 50.1% | | | | | 90.9% | | | | | | 59,480 | | | | | 20,166,034 | | | | | * | | | | | 100% | | | | | 50.0% | | | | | 90.9% | | | ||||||||||||
Blackrock Inc.(5) | | | | 2,737,895 | | | | | — | | | | | 13.5% | | | | | — | | | | | 6.8% | | | | | 1.2% | | | | | | 3,405,048 | | | | | — | | | | | 16.8% | | | | | — | | | | | 8.4% | | | | | 1.2% | | | ||||||||||||
The Vanguard Group(6) | | | | 1,972,052 | | | | | — | | | | | 9.8% | | | | | — | | | | | 4.9% | | | | | *% | | | | | | 2,141,888 | | | | | — | | | | | 10.6% | | | | | — | | | | | 5.3% | | | | | * | | | ||||||||||||
Virtus Fund Advisors LLC(7) | | | | 1,099,946 | | | | | | | | | | 5.4% | | | | | — | | | | | 2.7% | | | | | *% | | | |||||||||||||||||||||||||||||||||||||||||||
Executive Officers and Directors(8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||||||||||||||||
Jack C. Bendheim(4)(9) | | | | 59,480 | | | | | 20,166,034 | | | | | * | | | | | 100% | | | | | 50.1% | | | | | 90.9% | | | |||||||||||||||||||||||||||||||||||||||||||
Named Executive Officers and Directors(7) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||||||||||||||||
Jack C. Bendheim(4)(8) | | | | 59,480 | | | | | 20,166,034 | | | | | * | | | | | 100% | | | | | 50.0% | | | | | 90.9% | | | |||||||||||||||||||||||||||||||||||||||||||
Richard G. Johnson | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||
Daniel M. Bendheim(10) | | | | 37,280 | | | | | — | | | | | * | | | | | — | | | | | * | | | | | * | | | |||||||||||||||||||||||||||||||||||||||||||
Thomas G. Dagger | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||
Larry L. Miller | | | | — | | | | | — | | | | | * | | | | | — | | | | | — | | | | | — | | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||
Anthony Andolino | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | |||||||||||||||||||||||||||||||||||||||||||
Dean Warras(11) | | | | 31,560 | | | | | — | | | | | * | | | | | — | | | | | * | | | | | * | | | |||||||||||||||||||||||||||||||||||||||||||
Lisa A. Escudero | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | |||||||||||||||||||||||||||||||||||||||||||
Dean Warras | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | |||||||||||||||||||||||||||||||||||||||||||
Daniel Bendheim | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | |||||||||||||||||||||||||||||||||||||||||||
Jonathan Bendheim | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||
Gerald K. Carlson | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||
E. Thomas Corcoran | | | | 10,000 | | | | | — | | | | | * | | | | | — | | | | | * | | | | | * | | | | | | 20,000 | | | | | — | | | | | * | | | | | — | | | | | * | | | | | * | | | ||||||||||||
Sam Gejdenson | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||
Dr. George Gunn | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||
Mary Lou Malanoski | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | | | — | | | ||||||||||||
Carol A. Wrenn | | | | 1,000 | | | | | — | | | | | * | | | | | — | | | | | * | | | | | * | | | | | | 1,000 | | | | | — | | | | | * | | | | | — | | | | | * | | | | | * | | | ||||||||||||
Executive Officers and Directors as a Group (15 persons)(12)(13) | | | | 139,320 | | | | | 20,166,034 | | | | | 0.7% | | | | | 100% | | | | | 50.2% | | | | | 90.9% | | | |||||||||||||||||||||||||||||||||||||||||||
Executive Officers and Directors as a Group (17 persons) | | | | 80,480 | | | | | 20,166,034 | | | | | * | | | | | 100% | | | | | 50.0% | | | | | 90.9% | | |
Plan Category | | Number of securities to be issued upon exercise of outstanding options, warrants and rights | | Weighted-average exercise price of outstanding options, warrants and rights | | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) | | | Number of securities to be issued upon exercise of outstanding options, warrants and rights | | Weighted-average exercise price of outstanding options, warrants and rights | | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) | | ||||||||||||||||||||||||
Equity compensation plans approved by security holders | | | | — | | | | | — | | | | | — | | | | | | — | | | | | — | | | | | — | | | ||||||
Equity compensation plans not approved by security holders | | | | 345,900(1) | | | | $ | 11.83(2) | | | | | 4,881,620 | | | | | | 250,000(1) | | | | | — | | | | | 4,881,620 | | | ||||||
Total | | | | 345,900 | | | | | | | | | | 4,881,620 | | | | | | 250,000 | | | | | — | | | | | 4,881,620 | | |